ORIC Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.4%.

Top 25 shareholders own 92.67% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.62%	Pfizer Inc.	5,376,344	€50.7m	0%	no data
7.49%	Nextech Invest Ltd.	5,285,714	€49.8m	0%	7.29%
7.23%	BlackRock, Inc.	5,101,817	€48.1m	5.61%	no data
6.23%	VR Adviser, LLC	4,394,527	€41.4m	0%	1.99%
6.21%	FMR LLC	4,378,804	€41.3m	-11%	no data
5.87%	Frazier Life Sciences Management, LP	4,142,855	€39.0m	0%	1.57%
5.67%	Viking Global Investors LP	4,000,000	€37.7m	0%	0.13%
5.02%	The Column Group, LLC	3,540,777	€33.4m	0%	50.89%
4.84%	EcoR1 Capital, LLC	3,418,068	€32.2m	0%	1.11%
4.61%	Alkeon Capital Management, LLC	3,255,872	€30.7m	3.03%	0.23%
4.49%	The Vanguard Group, Inc.	3,167,311	€29.8m	-1.01%	no data
2.83%	Commodore Capital LP	2,000,000	€18.8m	0%	1.27%
2.75%	State Street Global Advisors, Inc.	1,938,169	€18.3m	-14.1%	no data
2.46%	Tavistock Life Sciences	1,732,571	€16.3m	0%	1.05%
2.13%	New Enterprise Associates, Inc.	1,500,000	€14.1m	0%	0.62%
2.06%	First Turn Management, LLC	1,451,037	€13.7m	-4.28%	2.24%
2.05%	Avidity Partners Management, L.P.	1,447,119	€13.6m	0%	0.76%
1.92%	ArrowMark Colorado Holdings, LLC	1,354,508	€12.8m	6.36%	0.16%
1.81%	Vivo Capital, LLC	1,277,818	€12.0m	0.64%	0.97%
1.8%	Geode Capital Management, LLC	1,273,513	€12.0m	4.16%	no data
1.6%	Balyasny Asset Management L.P.	1,131,066	€10.7m	0%	0.03%
1.58%	T. Rowe Price Group, Inc.	1,114,885	€10.5m	-6.25%	no data
1.56%	Silverarc Capital Management, LLC	1,099,490	€10.4m	2.2%	2.41%
1.43%	Invus Financial Advisors, LLC	1,007,575	€9.5m	0%	8.9%
1.43%	Artal Group S.A.	1,007,575	€9.5m	0%	0.25%